Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease

Elizabeth Riegelman,Kathy S. Xue,Jia-Sheng Wang,Lili Tang

DOI: https://doi.org/10.3390/nu16132041

IF: 5.9

2024-06-27

Nutrients

Abstract:With the recognition of the importance of the gut–brain axis in Parkinson's disease (PD) etiology, there is increased interest in developing therapeutic strategies that target α-synuclein, the hallmark abhorrent protein of PD pathogenesis, which may originate in the gut. Research has demonstrated that inhibiting the aggregation, oligomerization, and fibrillation of α-synuclein are key strategies for disease modification. Polyphenols, which are rich in fruits and vegetables, are drawing attention for their potential role in this context. In this paper, we reviewed how polyphenols influence the composition and functional capabilities of the gut microbiota and how the resulting microbial metabolites of polyphenols may potentially enhance the modulation of α-synuclein aggregation. Understanding the interaction between polyphenols and gut microbiota and identifying which specific microbes may enhance the efficacy of polyphenols is crucial for developing therapeutic strategies and precision nutrition based on the microbiome.

nutrition & dietetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the pathological role of α - synuclein in Parkinson's Disease (PD) and its relationship with the gut microbiota. Specifically, the research focuses on the following aspects:

1. **The role of α - synuclein in Parkinson's disease**:
- α - synuclein is normally present in the presynaptic terminals of neurons, but under pathological conditions, it will form oligomers and fibrils, leading to neuronal dysfunction and death.
- Inhibiting the aggregation, oligomerization and fibrillation of α - synuclein is a key strategy for disease modification.

2. **The role of the gut - brain axis**:
- The gut microbiota may play an important role in the pathogenesis of Parkinson's disease. Studies have shown that the composition of the gut microbiota in Parkinson's disease patients has changed.
- The gut - brain axis is a complex bidirectional communication system that connects the Enteric Nervous System (ENS) of the gastrointestinal tract and the Central Nervous System (CNS). This axis not only maintains the homeostasis of the gastrointestinal tract but may also be involved in the pathogenesis of neurodegenerative diseases.

3. **The influence of polyphenolic compounds**:
- Polyphenolic compounds (such as natural components in fruits and vegetables) have attracted attention because of their antioxidant and anti - inflammatory properties.
- The research explored how polyphenolic compounds affect the composition and function of the gut microbiota and how these microbial metabolites may enhance the regulation of α - synuclein aggregation.

4. **Potential treatment strategies**:
- Regulating the gut microbiota through dietary interventions may help reduce gut inflammation, enhance gut barrier function, and produce metabolites that can inhibit α - synuclein aggregation.
- Understanding the interactions among polyphenolic compounds, the gut - brain axis and α - synuclein pathology can provide new ways to prevent or slow down the progression of Parkinson's disease.

In summary, this paper aims to integrate current knowledge and the latest findings, reveal the complex interactions among polyphenolic compounds, the gut microbiota and α - synuclein aggregation, and provide insights for new treatment strategies for Parkinson's disease.